AI MARKET SCANNING

Cerus Corporation

📅 Next Catalyst: Nov 02, 2026 (🌙 Close) 🏛️ NASDAQ 📁 Healthcare 🏭 Medical Devices
AVG HISTORICAL GAP +0.79%
MAX GAP RECORD +32.51%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $CERS
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 02, 2026 Earnings Release 2026-11-02 (AFTER CLOSE (21:00)) 🔮 UPCOMING 🔒
Jul 30, 2026 Earnings Release 2026-07-30 (AFTER CLOSE)
-15.92%
Apr 30, 2026 Earnings Release 2026-04-30 (AFTER CLOSE)
+32.51%
Mar 02, 2026 Earnings Release 2026-03-02 (AFTER CLOSE)
-15.42%
Nov 06, 2025 Earnings Release 2025-11-06 (AFTER CLOSE)
+1.42%
Aug 05, 2025 Earnings Release 2025-08-05 (AFTER CLOSE)
+0.00%
Apr 30, 2025 Earnings Release 2025-04-30 (AFTER CLOSE)
+0.00%
Feb 20, 2025 Earnings Release 2025-02-20 (AFTER CLOSE)
+1.72%

VOLATILITY & GAP BIAS

AVG GAP MOVE 8.3%
Bullish Gaps (8)
Bearish Gaps (5)
Neutral / Flat (0)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $CERS

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company offers INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗